Objective: Alterations in chondrocyte differentiation and matrix remodeling play a central role in osteoarthritis (OA). Chondrocyte differentiation and remodeling are amongst others regulated by the so-called Bone Morphogenetic Proteins (BMPs). Although BMPs are considered protective for articular cartilage these factors can also be involved in chondrocyte hypertrophy and matrix degradation. This review is focused on these opposed roles of BMPs in OA development and progression. Methods: Peer reviewed publications published prior to August 2009 were searched in the Pubmed database. Articles that were relevant for the role of endogenous BMPs in OA were selected. Since good quality reviews on the application of BMP supplementation in cartilage tissue engineering have been described this subject has not been covered in this review. Results: BMPs can stimulate both chondrocyte matrix synthesis and chondrocyte terminal differentiation. The latter results in elevated matrix metalloproteinase-13 (MMP-13) production. Stimulation of matrix synthesis will be protective for cartilage while elevated MMP-13 activity will drive matrix degradation. What action of BMPs is dominant in OA is not yet elucidated and their role might be different in patient subgroups. Conclusion: BMPs can be protective for articular cartilage but can, due to their effect on chondrocyte differentiation, have harmful effects on articular cartilage and contribute to OA progression.
Introduction
The mammalian genome encodes over 40 different members of the transforming growth factor-b superfamily. The largest subfamily are the Bone Morphogenetic Proteins (BMPs). BMP activity was first identified in the early sixties but elucidation of the proteins responsible for the bone-inductive action was not achieved before the eighties 1 . Nowadays more than 20 BMPs are known and these proteins are involved in numerous cellular functions of which bone formation is just a small part.
The paradigm is that BMPs are protective for articular cartilage. We postulate that BMPs are not always protective but that BMPs can play a role in cartilage destruction and osteoarthritis (OA) progression. A dual role of BMPs in OA provides an explanation for the enigmatic observation that in OA both cartilage anabolism and catabolism are elevated. This review portrays the role of BMPs in cartilage development and how this role can not only be related to intrinsic cartilage repair but also to cartilage pathology like OA.
BMPs and BMP signaling
BMPs are highly conserved proteins and can function interchangeable throughout a large part of the animal kingdom, for example BMPs that function in humans also function in insects 2 .
These molecules are synthesized and secreted as precursor proteins and active BMP is only obtained after proteolytic cleavage of the prodomain 3 , although the latter has been challenged lately 4 . BMPs contain seven conserved cysteine knot domains. Six of those build an intramolecular cysteine knot, making the molecule relatively stable and heath resistant, and the seventh is used for intracellular dimerization with another BMP peptide 5, 6 . In general dimers of two similar molecules are formed but also the formation of heterodimers has been observed 7, 8 .
The mammalian BMPs can be segregated in several groups but the name giving within and between groups is rather confusing. BMP subgroups can be recognized based on amino acid sequence similarities (Table I) 9,10 . The subgroup containing Growth Differentiation Factor 9 (GDF9) and BMP-15 is more related to nodal than to the other BMPs while BMP-11 (GDF11) is related to the TGF beta's
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. BMP-1 is unrelated to other BMPs and is a protease that does not directly regulate the growth and differentiation of cells but can modulate the activity of TGF beta superfamily members 10, 11 . All BMPs, except BMP-1, regulate cell function by binding to specific membrane-bound receptors. In this review we restrict to the BMPs in Table I .
The main BMP signaling route is by means of specific, membrane-associated, type I and type II serine/threonine kinase receptors and their intracellular effectors, but other signaling routes also have been described, such as via TAK1 12, 13 . BMPs binds to a type II receptor with constitutive kinase activity after which a type I receptor is recruited (Fig. 1 The BMPs have been given their name for their role in bone induction and BMP signaling is considered to be essential for endochondral bone formation. An intermediate in this process of bone formation is cartilage. Since cartilage is the main tissue affected in OA and chondrocytes are considered to be crucial in OA the role of BMPs in chondrocyte differentiation will be discussed.
BMPs and chondrocyte differentiation
Cartilage development (chondrogenesis), as it can be observed amongst others in the developing embryo, the formation of osteophytes and fracture repair, is a strictly regulated process 24 . Mesenchymal precursor cells condensate and switch on chondrogenic differentiation. Differentiation of prechondrocytes into differentiated chondrocytes goes through a phase characterized by high cell proliferation and deposition of cartilage specific molecules, such as type II collagen and aggrecan. In the growth plate, the phase of differentiated chondrocytes is followed by chondrocyte terminal differentiation and endochondral ossification. During terminal differentiation chondrocytes become hypertrophic, characterized by cell enlargement and expression of type X collagen and MMP-13. Hypertrophic chondrocytes die by apoptosis and are finally replaced by bone. Alternatively, development of permanent articular cartilage at the end of the long bones is characterized by blocking terminal differentiation by, an until now, unknown mechanism. However, during OA, part of the chondrocytes in articular cartilage lose their stable phenotype and undergo changes that remind us of the alterations that normally only take place in terminally differentiating chondrocytes.
BMPs are involved in all phases of chondrogenesis and BMPs directly regulate the expression of several chondrocyte specific genes 25e27 . BMP activity is indispensable for correct cartilage formation. Blocking BMP activity by the use of noggin inhibits condensation of mesenchymal cells and the formation of chondrogenic aggregates 28 . The BMP-induced chondrogenic differentiation appears to be mediated through gap junction-mediated intercellular communication 29 .
BMPs not only stimulate condensation but have a strong effect on chondrocyte proliferation and matrix synthesis 24, 30 . In growth plate chondrocytes BMP-2, -4 and -5 up-regulated cell proliferation and matrix production 31, 32 . In developing mouse limbs BMP-2 and BMP-7 enhanced cell proliferation and expression of type II collagen mRNA 33, 34 . In cultured human normal articular ankle chondrocytes BMP-2, -4, and -7 stimulated aggrecan synthesis 35 . BMP activity has been demonstrated to regulate expression and activity of a transcription factor essential in chondrogenesis, sox9 27, 36 . BMP-2 overexpression resulted in accelerated up-regulation of sox9 gene expression in murine bone fractures indicating that enhancement of chondrogenesis by BMP-2 is mediated via a sox9-dependent pathway 37 . However, BMP activity not only elevates sox9 expression but also stimulates the chondrogenic capacity of sox9 by forming a sox9eCREB complex and promoting DNA binding 26, 27 . Although BMPs signal not solely via the Smad pathway, the canonical Smad pathway has been demonstrated to be vital for endochondral bone formation. In growth plates of rats Smad1 and Smad5 were highly expressed in proliferating chondrocytes and chondrocytes that underwent maturation. Retting et al. showed that deletion of individual Smads (1, 5 and 8) in a cartilage specific fashion resulted in viable and fertile mice while combined loss of Smads 1, 5 and 8 led to severe chondrodysplasia 38 . Mice without Smad1 and Smad8 or Smad5 and Smad8 appeared to be normal. Smad8 has a minor role in chondrogenesis while Smad1 and Smad5 are essential but interchangeable. Moreover, mice knock out for Smad1 and Smad8 and with only one functional allele of Smad5 were normal. Remarkably, the Smad1/5 knock out phenotype is more severe than that of Smad4 knock out mice, challenging the doctrine, at least in chondrocytes, that Smad4 is critical for Smad signaling through BMP pathways 38 .
Chondrocyte differentiation during endochondral bone formation appears to be controlled by Smad1 or Smad5 but also the transcription factor Runx2 plays an essential part in this process. In 
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. However, others reported that BMP-2 was hardly present in normal human articular cartilage while in osteoarthritic cartilage BMP-2 mRNA and protein were clearly detected in both clustering and individual chondrocytes 52, 53 . In isolated human chondrocytes, IL-1beta and TNFalpha increased BMP-2 mRNA and protein levels and mechanical injury of human cartilage explants resulted in increased expression of BMP-2 53, 54 . In mouse models of OA we detected strong upregulation of BMP-2 and BMP-4 neighboring cartilage lesions. Limited data are available about the role of locally produced BMPs in the protection against cartilage damage or stimulation of repair processes. Locally produced BMPs may play an important role in protection and regeneration of cartilage during and after inflammatory or traumatic damage or in osteoarthritic cartilage 55 .
In experimental arthritis overexpression of the BMP inhibitor noggin resulted in increased cartilage damage while noggin haploinsufficiency protected articular cartilage against destruction 56 .
We have found that blocking intrinsic BMP activity after an intraarticular IL-1-challenge using gremlin resulted in decreased aggrecan synthesis compared with IL-1 alone. Moreover, blocking BMP activity aggravated proteoglycan depletion showing that BMPs contributes to the intrinsic repair capacity of damaged cartilage 57 . These studies indicate that BMP activity is induced by inflammatory mediators and can play a role in enhancing cartilage repair and/or protection against cartilage damage. However, the observed BMP effects in these models might be mainly based on boosting the synthesis of matrix molecules such as aggrecan and type II collagen, the role that BMPs might have in modulating articular chondrocyte phenotype, and in this way on cartilage integrity, are not taken into account.
The activity of BMPs is controlled by a number of, more or less, specific inhibitors of which several have been detected in articular cartilage. Expression of the inhibitors noggin and follistatin has been detected in fetal, adult and osteoarthritic cartilage 50 .
However, Tardif and coworkers detected expression of gremlin, chordin, and follistatin by human chondrocytes but no expression of noggin. Follistatin and gremlin were significantly up-regulated in OA chondrocytes compared to normal chondrocytes 58 . In a histochemical study these authors reported low levels of follistatin and gremlin in normal cartilage and up-regulation of both proteins in cartilage of patients with advanced OA disease progression 59 . Activity of BMPs is not only controlled in the extracellular space but also intracellular. The intracellular inhibitors Smad6 and Smad7 are expressed, on mRNA and protein level, in normal and OA human cartilage but no changes were found in early or late OA cartilage 60 . It is not clear to what extend locally produced BMP inhibitors will control BMP activity in normal and OA cartilage. An elevated ratio of BMPs to inhibitors will increase BMP activity and will stimulate chondrocyte differentiation while a low ratio might impair synthesis of matrix molecules. How this ratio changes in OA cartilage and how this will affect the disease process is not identified yet.
Dual role of BMPs in OA
Chondrocyte differentiation is a carefully regulated process as discussed above. In the growth plate chondrogenesis is followed by chondrocyte terminal differentiation and endochondral ossification. During terminal differentiation chondrocytes become hypertrophic and remove the collagen matrix through the production of MMP -13 61e63 . Finally hypertrophic chondrocytes die by apoptosis and are replaced by bone. In the formation of articular cartilage terminal differentiation is prevented which results in permanent cartilage residing at the end of the long bones. However, during OA, chondrocytes in articular cartilage undergo phenotypic changes that bear resemblance to the alteration that occur in terminally differentiating chondrocytes, such as high MMP-13 synthesis 64, 65 .
BMPs are involved in all phases of chondrogenesis; mesenchymal condensation, chondrocyte proliferation, extracellular matrix deposition and finally terminal differentiation. BMP activity boosts all phases of chondrocyte differentiation 26,38,66e70 . Signaling via the so-called BMP-related receptor Smads is strictly required for chondrocyte terminal differentiation. Loss of both Smad1 and 5 leads to blockage of chondrocyte terminal differentiation and severe cartilage defects 38 . Mice overexpressing inhibitors of the Smad1/5/8 signaling route, Smad6 or Smurf1, show regular chondrocytes proliferation but blocked chondrocyte terminal differentiation 71 . Moreover, Smad6 inhibition with an antisense morpholino in differentiating chicken chondrocytes enhanced terminal differentiation, whereas overexpression of Smad6 blocked BMP-2-induced chondrocyte hypertrophy 72 . These results clearly indicate that BMP activity drives chondrocyte terminal differentiation. The direct, short term, effects of BMPs on MMP-13 expression are not straightforward, we (unpublished observation) and others have found stimulation of MMP-13 expression in chondrocytes but also inhibition or no effect has been reported. In normal and osteoarthritic human chondrocytes, stimulation with BMP-7 did not result in significant changes in MMP-13 expression 73 . On the other hand, in immortalized mouse chondrocytes stimulation with BMP-2 followed by IL-1 exposure led to increased expression of MMP-13 74 . In chondrosarcoma cells BMP-2 increased the expression and secretion of MMP-13 but inhibition of MMP-13 expression was found in fetal rat calvarial osteoblasts 75e77
. In C2C12 osteoblasts stably expressing canonical Wnt3a, exposure to BMP-2 resulted in elevated MMP-13 expression 78 . Not unexpectedly, long term culture of chondrocytes in the presence of BMP-2 has been shown to markedly up-regulate the expression of MMP-13. Chondrocyte-culture-derived tissue that was stimulated with BMP-2 was more frail than tissue cultured without BMP-2 79 . Apparently, although the short term effects of BMP activity are not clear-cut, the long term effects appear to point to elevated MMP-13 levels as a result of modulation of the chondrocyte phenotype.
BMP activity can stimulate the synthesis of matrix molecules but can also elevate MMP-13 expression by modulation of chondrocyte 85, 86 , will change the biological effects of BMPs on their target cells.
In conclusion, BMP activity can stimulate both chondrocyte matrix synthesis and MMP-13 production (Fig. 2) . What action of BMPs dominates in the OA process is not known and might be different between different patients and OA subtypes. Overall, BMPs and other members of the TGF-b superfamily, can be protective for articular cartilage but can also have a harmful role depending on changes in the biological context, such as for instance occur during aging. Future research into the role of these fascinating proteins in both OA progression and OA protection will provide indications for either supplementation or inhibition of specific BMPs, or their various signaling pathways, to treat OA. 
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